(Q53810400)

20 May 2018

title

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival. (English)

1 reference

20 May 2018

7

Jahn M Nesland

1 reference

20 May 2018

author name string

Zhenhe Suo

1

1 reference

20 May 2018

Bjørn Risberg

2

1 reference

20 May 2018

Mats G Kalsson

3

1 reference

20 May 2018

Kenneth Willman

4

1 reference

20 May 2018

Anne Tierens

5

1 reference

20 May 2018

Eva Skovlund

6

1 reference

20 May 2018

publication date

1 January 2002

1 reference

20 May 2018

published in

Journal of Pathology

1 reference

20 May 2018

volume

196

1 reference

20 May 2018

issue

1

1 reference

20 May 2018

page(s)

17-25

1 reference

20 May 2018

The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer

cites work

1 reference

Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer

21 January 2018

1 reference

Overexpression of EGFR and c‐erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts

21 January 2018

1 reference

The role of erbB2 signal transduction pathways in human breast cancer

21 January 2018

1 reference

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

Expression of the ERBB3 gene product in breast cancer

21 January 2018

1 reference

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.

21 January 2018

1 reference

Heregulin induces tyrosine phosphorylation of HER4/p180erbB4

21 January 2018

1 reference

Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types

21 January 2018

1 reference

c-erbB-4 protein expression in human breast cancer

21 January 2018

1 reference

Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2

21 January 2018

1 reference

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand‐receptor interactions

21 January 2018

1 reference

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

A Detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis

21 January 2018

1 reference

Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients

21 January 2018

1 reference

Assessment of tumor size for multifocal primary breast cancer

21 January 2018

1 reference

S-phase fraction and breast cancer--a decade of experience

21 January 2018

1 reference

Prognostic association of c-erbB-2 oncogene amplification and protein overexpression in human breast cancer using archival tissues. A comparative study

21 January 2018

1 reference

C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: Immunohistochemical analysis and clinicopathologic correlation

21 January 2018

1 reference

c-erbB-2 positive breast tumours behave more aggressively in the first years after diagnosis

21 January 2018

1 reference

ErbB-4 mRNA expression is decreased in non-metastatic pancreatic cancer

21 January 2018

1 reference

Dominance of ErbB-1 heterodimers in lung epithelial cells overexpressing ErbB-2. Both ErbB-1 and ErbB-2 contribute significantly to tumorigenicity

21 January 2018

1 reference

The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin

21 January 2018

1 reference

Specificity within the EGF family/ErbB receptor family signaling network

21 January 2018

1 reference

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

21 January 2018

1 reference

Mammalian cytoplasmic actins are the products of at least two genes and differ in primary structure in at least 25 identified positions from skeletal muscle actins

21 January 2018

1 reference

21 January 2018

1 reference

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

21 January 2018

1 reference

Expression of mRNA for heregulin and its receptor, ErbB-3 and ErbB-4, in human upper gastrointestinal mucosa

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.1003

1 reference

20 May 2018

1 reference

20 May 2018